The veterinary care industry is big. Some may argue that it is too big to the detriment of its own good. Perhaps its size makes it non-responsive and inflexible when it comes to providing specific care at the individual patient level. Others may argue that this size is a plus. It manages to impose a big defense and an expansive infrastructure of checks and balances.
The size can be good in the long term, but the victims of this size are often individual patients with very specific situations. It all leads back to access, and it is something Bova Compounding hopes to make an obsolete concern.
Stock Constraints Hold Specialists Back
When a peculiar situation arises, a veterinary care specialist may need access to a medication that is below the radar. It may be something not regularly stocked or fitted with tougher regulation. All this is well, but that result …